{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:03Z","timestamp":1790882343824,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.semnephrol.2009.01.004","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T08:15:24Z","timestamp":1239783324000},"page":"113-121","source":"Crossref","is-referenced-by-count":29,"title":["Role of Vitamin D in Chronic Kidney Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Tejas V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2009.01.004_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib2","unstructured":"USRDS morbidity and mortality 2007 data. [cited 2008 August 15]. Available from: http:\/\/www.usrds.org\/2007\/pdf\/06_hosp_morte_07.pdf."},{"key":"10.1016\/j.semnephrol.2009.01.004_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semnephrol.2005.05.002","article-title":"Predictors of cardiovascular death in ESRD","volume":"25","author":"Zoccali","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.semnephrol.2004.06.013","article-title":"Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism","volume":"24","author":"Martin","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jn\/134.6.1299","article-title":"The discovery of vitamin D: the contribution of Adolf Windaus","volume":"134","author":"Wolf","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib7","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/276287a0","article-title":"Site of 1,25(OH)2 vitamin D3 synthesis in the kidney","volume":"276","author":"Brunette","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jcb.10423","article-title":"New insights into the mechanisms of vitamin D action","volume":"88","author":"Christakos","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1515\/BC.2008.028","article-title":"Klotho as a regulator of oxidative stress and senescence","volume":"389","author":"Kuro-o","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","article-title":"Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization","volume":"16","author":"Liu","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib16","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ki.2008.218","article-title":"Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?","volume":"74","author":"Memon","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.ki.5002163","article-title":"Klotho: an antiaging protein involved in mineral and vitamin D metabolism","volume":"71","author":"Torres","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","article-title":"Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population","volume":"19","author":"Shoji","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(08)60251-2","article-title":"Activated vitamin D sterols in kidney disease","volume":"371","author":"Thadhani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib29","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric patients with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000190244","article-title":"Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis","volume":"77","author":"Goldsmith","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib32","first-page":"416","article-title":"Arterial calcification after vitamin D","volume":"1","author":"Berlyne","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib33","first-page":"51","article-title":"Ultrastructural study of hypervitaminosis D induced arterial calcification in Wistar rats","volume":"16","author":"Kingma","year":"1988","journal-title":"Artery"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","article-title":"Active serum vitamin D levels are inversely correlated with coronary calcification","volume":"96","author":"Watson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/excr.2002.5474","article-title":"1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2\/Cbfa1 gene promoter","volume":"274","author":"Drissi","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib37","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Cardus","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib39","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1093\/ndt\/gfn375","article-title":"Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats","volume":"23","author":"Noonan","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib40","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1525-139X.2003.160271.x","article-title":"Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure","volume":"16","author":"Foley","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib43","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","article-title":"Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography","volume":"93","author":"Pilz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib44","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib45","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.2008.219","article-title":"Targeted ablation of the vitamin D 1alpha-hydroxylase gene: getting to the heart of the matter","volume":"74","author":"Thadhani","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib48","series-title":"Effect of paricalcitol and calcitriol on cardiovascular disease in uninephrectomized ApoE knockout mice","author":"Becker","year":"2007"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","article-title":"Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial","volume":"83","author":"Schleithoff","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib51","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0021-9258(19)41849-8","article-title":"Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine","volume":"250","author":"Brumbaugh","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib52","series-title":"Deficiencies of 25D, 1,25D and inflammation are associated with albuminuria","author":"Levin","year":"2007"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib53","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1523-1755.2001.00775.x","article-title":"Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats","volume":"60","author":"Panichi","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib56","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib57","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)64129-6","article-title":"A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis","volume":"158","author":"Makibayashi","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jsbmb.2006.11.011","article-title":"Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis","volume":"103","author":"Tan","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib59","unstructured":"[cited 2008 June 9]. Available from: http:\/\/nobelprize.org\/nobel_prizes\/medicine\/laureates\/1929\/."},{"key":"10.1016\/j.semnephrol.2009.01.004_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000063556","article-title":"Incidence of infectious morbidity and mortality in dialysis patients","volume":"20","author":"Vanholder","year":"2002","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MNH.0b013e3282ff64a3","article-title":"Vitamin D and the immune system: role in protection against bacterial infection","volume":"17","author":"Bikle","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib62","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib63","first-page":"166","article-title":"Are chronic dialysis patients at increased risk for cancer?","volume":"21","author":"Mandayam","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/1535-7163.373.3.3","article-title":"Calcitriol in cancer treatment: from the lab to the clinic","volume":"3","author":"Beer","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1301\/nr.2003.jul.227-238","article-title":"Vitamin D and vitamin D analogs as cancer chemopreventive agents","volume":"61","author":"Guyton","year":"2003","journal-title":"Nutr Rev"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0037-1615681","article-title":"Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models","volume":"85","author":"Asakura","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib67","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","volume":"279","author":"Aihara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ki.5001595","article-title":"Pathogenic mechanisms for parathyroid hyperplasia","author":"Dusso","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1681\/ASN.2007040406","article-title":"EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease","volume":"19","author":"Arcidiacono","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib70","series-title":"Contribution of reduced parathyroid vitamin D receptor (VDR) to the switch from diffuse to nodular growth in secondary hyperparathyroidism","author":"Tokumoto","year":"2007"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.jrn.2008.04.008","article-title":"Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients","volume":"18","author":"Blair","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib72","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib73","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/ndt\/gfn367","article-title":"High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients","volume":"23","author":"Tokmak","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ki.5002002","article-title":"25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey","volume":"71","author":"Chonchol","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib77","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11906-008-0010-5","article-title":"Vitamin D and hypertension","volume":"10","author":"Hermann","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib80","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.1995.24","article-title":"Intravenous calcitriol normalizes insulin sensitivity in uremic patients","volume":"47","author":"Kautzky-Willer","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib81","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","article-title":"Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease","volume":"99","author":"Perez-Castrillon","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib82","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib83","series-title":"Combination therapy with paricalcitol and enalapril ameliorated cardiac oxidative injury in uremic rats","author":"Leon","year":"2007"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib84","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1046\/j.1523-1755.2000.00285.x","article-title":"Racial differences in survival of patients on dialysis","volume":"58","author":"Pei","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib85","series-title":"Racial differences in the prevalence and severity of disordered mineral metabolism in chronic kidney disease","author":"Gutierrez","year":"2007"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib86","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1681\/ASN.2007091002","article-title":"Impact of activated vitamin D and race on survival among hemodialysis patients","volume":"19","author":"Wolf","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.004_bib87","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1681\/ASN.2008060595","article-title":"Active vitamin D and survival","volume":"19","author":"Wolf","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T20:46:54Z","timestamp":1684961214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929509000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0270929509000059"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2009.01.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}